FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37280311000001109: Empagliflozin 10mg / Linagliptin 5mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
268091000001115 Empagliflozin 10mg / Linagliptin 5mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
268101000001114 Empagliflozin 10mg / Linagliptin 5mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Empagliflozin 10mg / Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Has specific active ingredient Empagliflozin true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Is a Empagliflozin + Linagliptin false Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets Is a Empagliflozin + Linagliptin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Empagliflozin 10mg / Linagliptin 5mg tablets 28 tablet Has VMP True Empagliflozin 10mg / Linagliptin 5mg tablets Inferred relationship Existential restriction modifier
Glyxambi 10mg/5mg tablets (Boehringer Ingelheim Ltd) Is a True Empagliflozin 10mg / Linagliptin 5mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start